Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Evaluation of superficial oral squamous cell malignancy based on morphometry and immunoexpression of cytokeratin 13 and cytokeratin 17.

Yamashina M, Sato K, Tonogi M, Tanaka Y, Yamane GY, Katakura A.

Acta Cytol. 2014;58(1):67-75. doi: 10.1159/000355865. Epub 2013 Nov 16.

PMID:
24247036
2.

Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma.

Kitamura R, Toyoshima T, Tanaka H, Kawano S, Kiyosue T, Matsubara R, Goto Y, Hirano M, Oobu K, Nakamura S.

J Cancer Res Clin Oncol. 2012 Aug;138(8):1299-310. doi: 10.1007/s00432-012-1202-6. Epub 2012 Apr 3.

3.

Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence.

Yanagawa T, Yoshida H, Yamagata K, Onizawa K, Tabuchi K, Koyama Y, Iwasa S, Shimoyamada H, Harada H, Omura K.

J Exp Clin Cancer Res. 2007 Jun;26(2):215-20.

PMID:
17725101
4.

Immunohistochemical staining patterns of cytokeratins 13, 14, and 17 in oral epithelial dysplasia including orthokeratotic dysplasia.

Nobusawa A, Sano T, Negishi A, Yokoo S, Oyama T.

Pathol Int. 2014 Jan;64(1):20-7. doi: 10.1111/pin.12125.

PMID:
24471966
5.

Cytokeratin 17: an adjunctive marker of invasion in squamous neoplastic lesions of the anus.

Nazarian RM, Primiani A, Doyle LA, Linskey KR, Duncan LM, Odze RD, Zukerberg LR.

Am J Surg Pathol. 2014 Jan;38(1):78-85. doi: 10.1097/PAS.0000000000000111.

PMID:
24335642
6.

BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia.

Linskey KR, Gimbel DC, Zukerberg LR, Duncan LM, Sadow PM, Nazarian RM.

Arch Pathol Lab Med. 2013 Nov;137(11):1591-8. doi: 10.5858/arpa.2012-0424-OA.

PMID:
24168496
7.
8.

Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.

Fernandez-Flores A.

Ann Diagn Pathol. 2016 Feb;20:1-6. doi: 10.1016/j.anndiagpath.2015.11.001. Epub 2015 Nov 10.

PMID:
26740287
9.

Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo.

Wei KJ, Zhang L, Yang X, Zhong LP, Zhou XJ, Pan HY, Li J, Chen WT, Zhang ZY.

Oral Dis. 2009 Jan;15(1):111-7. doi: 10.1111/j.1601-0825.2008.01501.x. Epub 2008 Nov 3.

PMID:
18992022
10.

Characteristics of basal cytokeratin expression in breast cancer.

Alshareeda AT, Soria D, Garibaldi JM, Rakha E, Nolan C, Ellis IO, Green AR.

Breast Cancer Res Treat. 2013 May;139(1):23-37. doi: 10.1007/s10549-013-2518-x. Epub 2013 Apr 16.

PMID:
23588953
11.

Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype.

Liu ZB, Wu J, Ping B, Feng LQ, Di GH, Lu JS, Shen KW, Shen ZZ, Shaol ZM.

Tumori. 2009 Jan-Feb;95(1):53-62.

12.

[Expression of cytokeratin 17 in oral squamous cell carcinoma].

Wei K, Zhang L, Yang X, Han W, Zhong L, Ye D, Zhiyuan Z.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2011 Aug;29(4):404-8. Chinese.

13.

Reduced expression of cytokeratin 4 and 13 is a valuable marker for histologic grading of esophageal squamous intraepithelial neoplasia.

Takashima M, Kawachi H, Yamaguchi T, Nakajima Y, Kitagaki K, Sekine M, Iida T, Takemura K, Kawano T, Eishi Y.

J Med Dent Sci. 2012 Mar 13;59(1):17-28.

PMID:
23896961
14.

Evaluation of specific marker CK13 and CK10/13 combined with APM staining for the diagnosis of amniotic fluid embolism and aspiration.

Wang J, Lai Q, Pan H, Sun D, Yu C, Zhang W, Chen J, Ma L, Li L, Zhou R.

Forensic Sci Int. 2014 May;238:108-12. doi: 10.1016/j.forsciint.2014.02.032. Epub 2014 Mar 12.

PMID:
24705378
15.

Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.

Ohta K, Ogawa I, Ono S, Taki M, Mizuta K, Miyauchi M, Takechi M, Shigeishi H, Takata T, Kamata N.

Oncol Rep. 2010 Jul;24(1):9-14.

PMID:
20514438
16.

Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.

Alves PM, Godoy GP, Gomes DQ, Medeiros AM, de Souza LB, da Silveira EJ, Vasconcelos MG, Queiroz LM.

Pathol Res Pract. 2011 Apr 15;207(4):236-40. doi: 10.1016/j.prp.2011.02.004. Epub 2011 Mar 11.

PMID:
21397408
17.

The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.

Xie X, Clausen OP, De Angelis P, Boysen M.

Cancer. 1999 Sep 15;86(6):913-20.

PMID:
10491515
18.

Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MS.

Thiel UJ, Feltens R, Adryan B, Gieringer R, Brochhausen C, Schuon R, Fillies T, Grus F, Mann WJ, Brieger J.

J Oral Pathol Med. 2011 May;40(5):369-79. doi: 10.1111/j.1600-0714.2010.00982.x. Epub 2010 Dec 17.

PMID:
21166718
19.

The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer.

Chen Y, Cui T, Yang L, Mireskandari M, Knoesel T, Zhang Q, Pacyna-Gengelbach M, Petersen I.

Oncology. 2011;80(5-6):333-40. doi: 10.1159/000329098. Epub 2011 Jul 26.

PMID:
21791943

Supplemental Content

Support Center